These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8285610

  • 1. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.
    Patterson TF, Fothergill AW, Rinaldi MG.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2307-10. PubMed ID: 8285610
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
    Denning DW, Hall L, Jackson M, Hollis S.
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.
    Dannaoui E, Meletiadis J, Tortorano AM, Symoens F, Nolard N, Viviani MA, Piens MA, Lebeau B, Verweij PE, Grillot R, And The Ebga Network.
    J Med Microbiol; 2004 Feb; 53(Pt 2):129-134. PubMed ID: 14729934
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA, Morrissey G, Morrissey J, Denning DW.
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.
    Kirkpatrick WR, McAtee RK, Fothergill AW, Loebenberg D, Rinaldi MG, Patterson TF.
    Antimicrob Agents Chemother; 2000 Mar; 44(3):780-2. PubMed ID: 10681359
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.
    Berenguer J, Ali NM, Allende MC, Lee J, Garrett K, Battaglia S, Piscitelli SC, Rinaldi MG, Pizzo PA, Walsh TJ.
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1303-8. PubMed ID: 8092829
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
    Kirkpatrick WR, McAtee RK, Fothergill AW, Rinaldi MG, Patterson TF.
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2865-8. PubMed ID: 10991875
    [Abstract] [Full Text] [Related]

  • 13. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
    Paterson PJ, Seaton S, Prentice HG, Kibbler CC.
    J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
    [Abstract] [Full Text] [Related]

  • 14. Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model.
    Patterson TF, Miniter P, Ryan JL, Andriole VT.
    J Infect Dis; 1988 Aug; 158(2):415-22. PubMed ID: 3042878
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
    George D, Miniter P, Andriole VT.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):86-91. PubMed ID: 8787885
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of fluconazole in experimental invasive aspergillosis.
    Patterson TF, Miniter P, Andriole VT.
    Rev Infect Dis; 1990 Jan; 12 Suppl 3():S281-5. PubMed ID: 2184506
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
    Oakley KL, Morrissey G, Denning DW.
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
    [Abstract] [Full Text] [Related]

  • 18. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.
    Denning DW, Radford SA, Oakley KL, Hall L, Johnson EM, Warnock DW.
    J Antimicrob Chemother; 1997 Sep; 40(3):401-14. PubMed ID: 9338494
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
    Allendoerfer R, Loebenberg D, Rinaldi MG, Graybill JR.
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
    [Abstract] [Full Text] [Related]

  • 20. Acquired itraconazole resistance in Aspergillus fumigatus.
    Dannaoui E, Borel E, Monier MF, Piens MA, Picot S, Persat F.
    J Antimicrob Chemother; 2001 Mar; 47(3):333-40. PubMed ID: 11222566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.